Identifying risk factors for lung function loss after severe pneumonia in adults with AIDS
Studies which factors predict lung function damage in adults with AIDS recovered from severe pneumonia.
Plain-language title generated from the registry record
Registry title: Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia
Key facts
- Where
- Guangzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06137196, who can take part
Where in China
- Guangzhou Eighth People's Hospital, Guangzhou Medical UniversityGuangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Guangzhou 8th People's Hospital
- Trial code
- NCT06137196
- Record updated
- 18 November 2023
- Original description
Screening for risk factors related to lung function impairment in patients who have recovered from AIDS with severe pneumonia, to provide clinical evidence for early identification and intervention of lung function damage in this population.Read full original descriptionShow less
Study on Risk Identification Factors for Lung Function Impairment in AIDS Patients Recovered From Severe Pneumonia
Screening for risk factors related to lung function impairment in patients who have recovered from AIDS with severe pneumonia, to provide clinical evidence for early identification and intervention of lung function damage in this population.
Inclusion: Confirmed HIV infection; Progression to the AIDS stage: CD4+ count <200 cells/µL and/or occurrence of opportunistic infections associated with AIDS; Age between 18 to 65 years; Meet the diagnostic criteria for severe pneumonia, with reference to the 2021 treatment guidelines for community-acquired pneumonia developed by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA).
Exclusion: Concurrent central nervous system lesions, severe liver disease, or cirrhosis; Concurrent AIDS-related or non-related tumors; Alcohol abuse or drug use; Presence of serious underlying diseases such as heart, lung, liver, kidney, etc; The researcher believes that the overall condition of the subject affects the evaluation and completion of the trial; Women who are pregnant or breastfeeding.